HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Abram Selected Research

Tenofovir (Viread)

4/2013A randomized, double-blind comparison of coformulated elvitegravir/cobicistat/emtricitabine/tenofovir DF vs ritonavir-boosted atazanavir plus coformulated emtricitabine and tenofovir DF for initial treatment of HIV-1 infection: analysis of week 96 results.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Abram Research Topics

Disease

1Infections
04/2013

Drug/Important Bio-Agent (IBA)

1elvitegravirIBA
04/2013
1Emtricitabine (Emtriva)FDA Link
04/2013
1Tenofovir (Viread)FDA Link
04/2013
1Atazanavir Sulfate (Reyataz)FDA Link
04/2013
1CobicistatIBA
04/2013
1Ritonavir (Norvir)FDA Link
04/2013